Concepedia

M.A. Bergamino

MB

Statistics

Publications

2

Citations

61

H-Index

2

Active since

2019

Affiliations

Queen's Medical Centre(Current)

M.A. Bergamino is an author at Queen's Medical Centre specializing in oncology, medicine, and breast cancer resistance mechanisms.

Publications per year

2019–2022

2

Publications

2

Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy

M.A. Bergamino, Antonio Rullan, Maria Saigí et al. · BMC Cancer · 2019 · 34 citations · Full text

, , +15

HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer

M.A. Bergamino, Elena López‐Knowles, Gabriele Morani et al. · EBioMedicine · 2022 · 27 citations · Full text

, , +15

1–2 of 2